Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by MacDonald, A. G.
Right arrow Articles by Fraser, W. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MacDonald, A. G.
Right arrow Articles by Fraser, W. D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

The British Journal of Rheumatology, Vol 36, 50-53, Copyright © 1997 by British Society for Rheumatology


ORIGINAL PAPERS

Biochemical markers of bone turnover in seronegative spondylarthropathy: relationship to disease activity

AG MacDonald, G Birkinshaw, B Durham, RC Bucknall and WD Fraser
Department of Rheumatology, Royal Liverpool University Hospital.

To investigate bone turnover in patients with seronegative spondylarthropathy, a bone formation marker, type 1 procollagen carboxy- terminal propeptide (P1CP), and resorption markers, the pyridinium cross-links of collagen [urinary free (f) PYR and DPYR], were measured. The median f-PYR, f-DPYR and P1CP (+/-interquartile range) were 15.8 (6.00) nmol/mmol creatinine, 3.8 (2.2) nmol/mmol creatinine and 101.5 (38) micrograms/1, respectively. There was a positive correlation between resorption markers and acute-phase reactants such as C-reactive protein (r = 0.42 for PYR, r = 0.42 for DPYR, P < 0.05), and a negative correlation observed between P1CP and the erythrocyte sedimentation rate (r = -0.64, P < 0.05). In the subgroup of patients with an elevated CRP concentration, the concentration of PYR and DPYR was significantly increased (f-PYR 25.7 vs 15.8 and f-DPYR 6.6 vs 3.8, P < 0.01 for f-PYR, P < 0.05 for f-DPYR). This study suggests than an elevation in acute-phase response in patients with seronegative spondylarthropathy is associated with increased concentration of bone resorption markers with a tendency for reduction in bone formation markers. This may represent uncoupling of bone formation and resorption, leading to bone loss in such patients.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Ann Rheum DisHome page
S Visvanathan, D van der Heijde, A Deodhar, C Wagner, D G Baker, J Han, and J Braun
Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis
Ann Rheum Dis, February 1, 2009; 68(2): 175 - 182.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
D. Vosse, R. Landewe, P. Garnero, D. van der Heijde, S. van der Linden, and P. Geusens
Association of markers of bone- and cartilage-degradation with radiological changes at baseline and after 2 years follow-up in patients with ankylosing spondylitis
Rheumatology, August 1, 2008; 47(8): 1219 - 1222.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
H. M Macdonald, F. E McGuigan, S. A Lanham-New, W. D Fraser, S. H Ralston, and D. M Reid
Vitamin K1 intake is associated with higher bone mineral density and reduced bone resorption in early postmenopausal Scottish women: no evidence of gene-nutrient interaction with apolipoprotein E polymorphisms
Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1513 - 1520.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
H. M Macdonald, S. A New, W. D Fraser, M. K Campbell, and D. M Reid
Low dietary potassium intakes and high dietary estimates of net endogenous acid production are associated with low bone mineral density in premenopausal women and increased markers of bone resorption in postmenopausal women
Am. J. Clinical Nutrition, April 1, 2005; 81(4): 923 - 933.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
F Allali, M Breban, R Porcher, J F Maillefert, M Dougados, and C Roux
Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor {alpha}
Ann Rheum Dis, April 1, 2003; 62(4): 347 - 349.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
H. W. Vesper, L. M. Demers, R. Eastell, P. Garnero, M. Kleerekoper, S. P. Robins, A. K. Srivastava, G. R. Warnick, N. B. Watts, and G. L. Myers
Assessment and Recommendations on Factors Contributing to Preanalytical Variability of Urinary Pyridinoline and Deoxypyridinoline
Clin. Chem., February 1, 2002; 48(2): 220 - 235.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. E. Clark, A. J. Flory, E. M. Ion, B. E. Woodcock, B. H. Durham, and W. D. Fraser
Biochemical markers of bone turnover following high-dose chemotherapy and autografting in multiple myeloma
Blood, October 15, 2000; 96(8): 2697 - 2702.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
S. M Husain, Z. Mughal, G. Williams, K. Ward, C. S Smith, J. Dutton, and W. D Fraser
Urinary excretion of pyridinium crosslinks in healthy 4-10 year olds
Arch. Dis. Child., April 1, 1999; 80(4): 370 - 373.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.